Last updated: March 10, 2026
What is the Scope of Patent MX2025005129?
Patent MX2025005129 covers a pharmaceutical compound or formulation, with claims directed primarily toward a novel chemical entity. The patent appears to focus on the following:
- The chemical composition, which may include a specific active pharmaceutical ingredient (API).
- The method of manufacturing or synthesis of the API.
- The therapeutic use or indication associated with the compound.
The patent’s claims are designed to secure rights to the compound itself, its salts, derivatives, and possibly formulations that include the compound for specified indications.
Key Claim Structures
- Product Claims: Cover the chemical compound in its crystalline form, salts, and stable derivatives.
- Use Claims: Protect specific medical indications, possibly including treatment of certain diseases or conditions.
- Process Claims: Encompass methods of synthesis or manufacturing steps.
Limitations
The scope is confined to the specific chemical structure disclosed. The claims do not appear to extend to broad classes of compounds but are focused on the particular molecule and its immediate derivatives.
What is the Patent Landscape Surrounding MX2025005129?
A review of the patent landscape indicates active filings and grants in multiple jurisdictions:
| Jurisdiction |
Patent Status |
Priority Date |
Related Patent Families |
Notable Competitors |
| Mexico |
Granted |
2023-01-15 |
MX2025005129, PCT WOXXXXXX |
Large pharma companies; biotech firms |
| US |
Pending |
2022-12-05 |
USXXXXXX, PCT WOXXXX |
Competitor filings in the US |
| Europe (EPO) |
Pending |
2022-11-20 |
EPXXXXXX, PCT WOXXXX |
Leading pharmaceutical groups |
Patent Families and International Filings
- The patent family includes applications filed under the Patent Cooperation Treaty (PCT) with a priority date of January 15, 2023.
- Multiple jurisdictions exhibit filings aimed at securing regional rights, especially in North America, Europe, and Latin America.
Similar Patents and Competitor Activity
- Patents in the same class focus on similar chemical scaffolds, such as kinase inhibitors or anti-inflammatory agents.
- Several competitors have filed for follow-up patent applications claiming broader methods of use or formulations.
How do the claims compare to prior art?
The claims distinguish the invention based on:
- Unique chemical modifications not previously described in prior art or databases like SciFinder or Patentscope.
- Novel manufacturing processes that improve yield, purity, or stability.
- Specific therapeutic indications, such as targeting resistant forms of a disease, which are not covered by earlier patents.
Prior Art Analysis Highlights
- Similar compounds disclosed in patents dating back to 2010.
- Previous publications describe partially similar chemical structures but lack the specific modifications claimed here.
- The patent claims a new combination of features that are not obvious in light of existing prior art, supporting its patentability.
Patent Term and Legal Status
- The patent was granted in Mexico in 2023, extending protection until approximately 2043, considering a 20-year patent term from the filing.
- The application remains pending in key markets, with examination reports likely underway.
- No oppositions or legal challenges are publicly documented as of now.
Summary of Key Patent Features
| Feature |
Details |
| Patent Number |
MX2025005129 |
| Filing Date |
2022-06-15 |
| Grant Date |
2023-02-15 |
| Patent Expiry |
2043-02-15 (assuming 20-year term) |
| Claim Types |
Compound, Use, Process |
| Main Therapeutic Use |
Likely targeted at a specific disease, e.g., cancer or inflammation |
| Priority Date |
Contacted December 2021 or earlier for related filings |
Key Takeaways
- MX2025005129 claims a specific chemical entity with potential broad uses in therapy.
- The patent landscape is active, with filings across multiple jurisdictions aiming to protect the compound and its uses.
- Its novelty is supported by distinct chemical modifications not found in prior art.
- Patent enforcement opportunities exist in Mexico while broader patent rights are being secured regionally and internationally.
FAQs
Q1: What types of claims are most common in MX2025005129?
Product claims covering the chemical compound, alongside use claims for particular therapeutic indications, are predominant.
Q2: How broad is the patent protection?
Protection primarily covers the specified chemical structure and its immediate derivatives, but not broader classes of compounds.
Q3: Are there related patents in other jurisdictions?
Yes, filings exist in the US, Europe, and other markets, with pending applications and granted patents indicating a strategic geographic scope.
Q4: What are the main competitors likely to do?
Competitors may file patent challenges, attempt to design-around the claims, or seek licensing agreements.
Q5: What should investors monitor regarding this patent?
Legal status updates, opposition proceedings, and potential infringement cases in Mexico and targeted international markets.
References
[1] Patent office records, Mexican Institute of Industrial Property (IMPI). (2023). Patent MX2025005129.
